Long-chain polyunsaturated fatty acids
Showing 1 - 25 of >10,000
Analysis of Lipids in Human Milk at Different Gestational Ages
Recruiting
- Breast Milk Collection
- Breastfeeding
-
Salerno, Naples, Italy
- +1 more
Aug 13, 2023
Obesity Trial in Potchefstroom (Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA))
Recruiting
- Obesity
- Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA)
-
Potchefstroom, South AfricaCentre of Excellence for Nutrition, North-West University
Oct 25, 2022
Acute Lymphoblastic Leukemia, Vitamin d Deficiency Trial in Mexico City (?-3 polyunsaturated fatty acids (DHA and EPA), Vitamin
Recruiting
- Acute Lymphoblastic Leukemia
- Vitamin d Deficiency
- ω-3 polyunsaturated fatty acids (DHA and EPA), Vitamin D (cholecalciferol), Calcium (calcium carbonate)
-
Mexico City, MexicoUnit of research in Nutrition, Pediatric Hospital, Instituto Mex
Jul 10, 2023
Pulmonary Hypertension of Newborn, Diaphragm Defect Trial in Mexico (lipid injectable emulsion with Fish oil)
Recruiting
- Pulmonary Hypertension of Newborn
- Diaphragm Defect
- lipid injectable emulsion with Fish oil
-
Mexico, Ciudad De Mexico, MexicoUnit of Medical Research in Nutrition
Dec 14, 2021
Atrial Fibrillation Trial in Montreal (OMEGA-3, Placebo soybean oil)
Completed
- Atrial Fibrillation
- OMEGA-3
- Placebo soybean oil
-
Montreal, Quebec, CanadaMontreal Heart Institute Coordinating Center
Mar 1, 2022
Retinopathy of Prematurity Trial in La Jolla (Omegaven, Standard lipids (primarily omega-6 fatty acids))
Completed
- Retinopathy of Prematurity
- Omegaven
- Standard lipids (primarily omega-6 fatty acids)
-
La Jolla, CaliforniaUniversity of California, San Diego Jacobs Medical Center
Dec 13, 2021
Type 1 Diabetes Trial (omega-3 supplementation, Vitamin D supplementation)
Completed
- Type 1 Diabetes Mellitus
- omega-3 supplementation
- Vitamin D supplementation
- (no location specified)
Mar 23, 2021
Lifestyle Trial in Adelaide, Singapore (Experimental: Control, Experimental: Treatment 1 - Semi-Solid food matrix, Treatment 2 -
Unknown status
- Lifestyle
- Experimental: Control
- +2 more
-
Adelaide, South Australia, Australia
- +1 more
Oct 29, 2020
Anorexia Nervosa Trial in Leuven (Short-chain fatty acids (SCFAs), Placebo)
Not yet recruiting
- Anorexia Nervosa
- Short-chain fatty acids (SCFAs)
- Placebo
-
Leuven, Vlaams Brabant, BelgiumUZ/KU Leuven
Sep 29, 2023
n-3 Polyunsaturated Fatty Acids Trial in Osijek (N-3 PUFAs Chicken Meet, Regular Chicken Meet)
Recruiting
- n-3 Polyunsaturated Fatty Acids
- N-3 PUFAs Chicken Meet
- Regular Chicken Meet
-
Osijek, CroatiaScientific Center of Excellence for Personalized Health Care, Jo
Feb 2, 2023
Systemic Availability, Intestinal Absorption, Metabolism Trial in Leuven (SCFA)
Recruiting
- Systemic Availability
- +3 more
- SCFA
-
Leuven, BelgiumKU Leuven
Oct 13, 2023
Aerobic Endurance, Metabolism Trial in Natick (High-amylose maize starch+acetate/butyrate, Low-amylose maize starch)
Recruiting
- Aerobic Endurance
- Metabolism
- High-amylose maize starch+acetate/butyrate
- Low-amylose maize starch
-
Natick, MassachusettsUnited States Army Research Institute of Environmental Medicine
Sep 19, 2023
Dyslipidemias, Fatty Acid; Metabolic Disorder Trial in Padova (dark chocolate, White chocolate)
Completed
- Dyslipidemias
- Fatty Acid; Metabolic Disorder
- dark chocolate
- White chocolate
-
Padova, ItalyUniversity of Padova
Oct 3, 2023
Healthy Trial in Philadelphia (Fish Oil, Safflower Oil, Ethanol)
Active, not recruiting
- Healthy
- Fish Oil
- +4 more
-
Philadelphia, PennsylvaniaInstitute for Translational Medicine and Therapeutics (ITMAT), U
Dec 22, 2022
Diabetic Neuropathies Trial in Saint Louis (Fish-oil derived n-3 polyunsaturated fatty acids)
Recruiting
- Diabetic Neuropathies
- Fish-oil derived n-3 polyunsaturated fatty acids
-
Saint Louis, Missouri
- +1 more
Jun 15, 2022
Episodic Migraine Trial in Taichung (Vitamin D, Non-Vitamin D)
Recruiting
- Episodic Migraine
- Vitamin D
- Non-Vitamin D
-
Taichung, TaiwanKuang Tien General Hospital
Jul 7, 2022
Periodontitis, Therapeutics, Fatty Acids, Unsaturated Trial in Lodz (fish oil, SRP only)
Completed
- Periodontitis
- +2 more
- fish oil
- SRP only
-
Lodz, PolandDepartment of Periodontology and Oral Mucosal Diseases
Jul 27, 2022
Lipemia Trial in Amman (Coconut oil, Palm oil)
Recruiting
- Lipemia
- Coconut oil
- Palm oil
-
Amman, Jordan
- +1 more
Sep 12, 2022
Lipoprotein Metabolism, PCSK9, Proteomics Trial run by the NHLBI (control fish oil, LCMUFA-rich saury oil)
Completed
- Lipoprotein Metabolism
- +2 more
- control fish oil
- LCMUFA-rich saury oil
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 3, 2020
Type 2 Diabetes, Lipid Metabolism Disorder, Fatty Acid Metabolism Disorder Trial in Lianshui (omega-3 polyunsaturated fatty
Completed
- Type 2 Diabetes Mellitus
- +2 more
- omega-3 polyunsaturated fatty acids
- corn oil
-
Lianshui, Jiangsu, ChinaLian Shui People's Hospital
Oct 2, 2023
Long Chain Fatty Acid Oxidation Disorders
Not yet recruiting
- Long-chain Fatty Acid Oxidation Disorders \(LC-FAOD\)
- Intermittent cardiopulmonary exercise test
- +4 more
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location AMC
Jun 21, 2023
Alcohol Use Disorder, Severe Trial (Active Comparator: Omega-3, Placebo Comparator: olive oil)
Not yet recruiting
- Alcohol Use Disorder, Severe
- Active Comparator: Omega-3
- Placebo Comparator: olive oil
- (no location specified)
Jun 1, 2023
Hypertriglyceridemia Trial in Munich (MCT, SFA, MUFA)
Completed
- Hypertriglyceridemia
- MCT
- +2 more
-
Munich, GermanyUniversity Munich
Sep 13, 2021
Obesity, Insulin Resistance Trial in Mexico City (Omega3 and an hypocaloric diet., Sunflower oil with an hypocaloric diet.)
Completed
- Obesity
- Insulin Resistance
- Omega3 and an hypocaloric diet.
- Sunflower oil with an hypocaloric diet.
-
Mexico City, MexicoUnit or research in Medical Nutrition, Pediatric Hospital CMN "S
Jan 20, 2020
Kidney Transplantation Trial in Norway (Omacor, Placebo Oral Capsule)
Active, not recruiting
- Kidney Transplantation
- Omacor
- Placebo Oral Capsule
-
Lørenskog, Akershus, Norway
- +5 more
Oct 18, 2022